MicroRNA-21 as a Potential Biomarker for Colorectal Cancer Diagnosis: A Meta-analysis
Chao-Hui Zhen, Guo-Jun Yao, Yan Tan, Lu Yang, Xiao-Fang Yu, Fu-Rong Li
Journal of Advances in Medicine and Medical Research · pp. 1–13 · Published 31 Aug 2016
10.9734/BJMMR/2016/27261Abstract
Aims: Colorectal cancer (CRC) occupies an important position in the morbidity and mortality constitution of malignancies. In recent years, mounting literature has reported about the upregulating expression of microRNA-21 in blood and stool of CRC patients, which suggested that microRNA-21 may become a novel potential biomarker for CRC. Consequently, this meta-analysis was designed to systematically review the values of microRNA-21 in CRC diagnosis. Methodology: Databases, including Cochrane library, PubMed, EMbase, Google Scholar, and Chinese National Knowledge Infrastructure, were scanned to retrieve relevant articles focusing on microRNA-21 in CRC diagnosis. Articles were then filtered according to the PRISMA statement and assessed by quality assessment of diagnosis accuracy studies-2. Sensitivity (SEN), specificity (SPE), positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio (DOR) were pooled using fixed-effects model or random-effects model. Summary receiver operating characteristic (SROC) curve and area under the curve (AUC) were used to estimate the overall diagnostic performance. Results: A total of 15 studies, comprising 1268 CRC patients and 910 healthy controls, were enrolled in this meta-analysis. For serum miR-21, the pooled DOR, SEN, and SPE were 13.97 (95% CI: 8.44–23.11), 0.73 (95% CI: 0.69–0.77), and 0.83 (95% CI: 0.76–0.89), respectively; for plasma miR-21, the pooled DOR, SEN, and SPE were 8.03 (95% CI: 3.30–19.52), 0.67 (95% CI: 0.60–0.73), and 0.76 (95% CI: 0.69–0.81), respectively; and for fecal miR-21, the pooled DOR, SEN, and SPE were 7.06 (95% CI: 2.17–22.95), 0.33 (95% CI: 0.28–0.37), and 0.91 (95% CI: 0.88–0.93), respectively. Moreover, the AUC values of serum, plasma, and fecal miR-21 in CRC diagnosis were 0.8701, 0.8295, and 0.6742, respectively. Conclusion: Blood miR-21 demonstrates good diagnostic performance, and serum samples are better than plasma samples in CRC diagnosis. For fecal miR-21, the sensitivity is unsatisfactory, but the specificity is favorable in predicting CRC patients.
Cited by 1
Mennatallah S. Elaguizy, M. Sheta, Nahed Ibrahim · Journal of B.U.ON. : official journal of the Balkan Union of Oncology · 2020
Related research
- Maternal Age and Congenital Anomalies among Newborns in a Tertiary Health Facility in Benue State, North Central Nigeria — shares topic coverage
- Early Diagnosis of Neonatal Sepsis: A Review of the Current Methods in Clinical Practice — shares topic coverage
- Skeletal Dysplasia: Approach to Simplify Diagnosis, Looking for Radiographic Clue Signs — shares topic coverage
- Impact of Radiology on the Early Identification of Waterhouse-friderichsen Syndrome: A Case Study — shares topic coverage
- The Impact of Genexpert MTB/RIF Technology on the Minimization of Tuberculosis: A Review of Literature — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.